Reuters

(Reuters) - German producer prices fell more than expected in April due mainly to lower energy prices, the federal statistics office reported on Tuesday.

Producer prices decreased by 3.3% on the year. Analysts polled by Reuters had expected a 3.1% decline.

Energy prices were down 8.2% year-on-year in April, due mainly to lower prices for natural gas and electricity, the statistics office said.

Excluding energy prices,... (continue reading...)

JENIN, West Bank (Reuters) - Israeli forces raided Jenin in the occupied West Bank on Tuesday in an operation that the Palestinian health ministry said killed three Palestinians and left eight others wounded.

The army said it was an operation against militants and several Palestinian gunmen were shot.

(Reporting by Ali Sawafta and Clauda Tanios; Editing by Sonali Paul and Andrew Heavens)

KYIV (Reuters) - Ukrainian forces shot down 28 out of 29 drones used by Russian forces in an overnight attack on seven regions, Ukraine’s air force said in a statement on Tuesday.

The drone attack damaged four private residences, 25 trucks and buses in Kharkiv, injuring five people, according to the region's governor Oleh Syniehubov and Ukrainian Internal Affairs Ministry's statements on the Telegram messaging app.

A missile attack... (continue reading...)

By Layli Foroudi and Maya Gebeily

PARIS (Reuters) - Three senior Syrian officials will face trial in absentia in a Paris court on Tuesday accused of involvement in the disappearance and subsequent death of a French-Syrian father and his son.

It is the first time that a serving Syrian official will go on trial for alleged war crimes.

The long-running case revolves around the disappearance and subsequent death of father Mazen... (continue reading...)

(Reuters) - French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence.

Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources.